The Joint Commission Update for Infection Control

Follow the fab four

The elements of performance for the CAUTI prevention safety goal are as follows:

1. During 2012, plan for the full implementation of this NPSG by January 1, 2013.

Note: Planning may include a number of different activities, such as assigning responsibility for implementation activities, creating timelines, identifying resources, and pilot testing.

2. Insert indwelling urinary catheters according to established evidence-based guidelines that address the following:

— Limiting use and duration to situations necessary for patient care

— Using aseptic techniques for site preparation, equipment and supplies

3. Manage indwelling urinary catheters according to established evidence-based guidelines that address the following:

— Securing catheters for unobstructed urine flow and drainage

— Maintaining the sterility of the urine collection system

— Replacing the urine collection system when required

— Collecting urine samples

4. Measure and monitor catheter-associated urinary tract infection prevention processes and outcomes in high-volume areas by doing the following:

— Selecting measures using evidence-based guidelines or best practices

— Monitoring compliance with evidence-based guidelines or best practices

— Evaluating the effectiveness of prevention efforts

The draft National Patient Safety Goal was made available for field comment on The Joint Commission's website from December 2, 2010 through January 27, 2011. More than 1,000 responses were received with most responses from accredited organizations. A majority of field review respondents (more than 70%) agreed that a new National Patient Safety Goal should be introduced for CAUTI, the Joint Commission said.


  1. Centers for Disease Control and Prevention. Available at:
  2. Klevens RM, Edward JR, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Reports 2007;122:160-166.
  3. Joint Commission. R3 Report. "Catheter-associated urinary tract infections: Issue 2, September 28, 2011, available at:
  4. Saint S., Chenoweth C.E.: Biofilms and catheter-associated urinary tract infections. Infect Dis Clin North Am: 2003; 17(2):411-432
  5. Johnson J.R., et al. Prevention of catheter-associated urinary tract infection with a silver-oxide-coated urinary catheter: clinical and microbiologic correlation. J Infect Dis 1990;62(5):1145-1150.
  6. Riley D.K., et al: A large, randomized clinical trial of a silver-impregnated urinary catheter: Lack of efficacy and staphylococcal superinfection. Am J Med 1995: 98(4):349-356
  7. Rebmann T., Greene, L.R. Preventing catheter-associated urinary tract infections: An executive summary of the Association for Professionals in Infection Control and Epidemiology, Inc. Elimination Guide. AJIC 2010; 38(8):644-646.
  8. Fuchs, M.A., et al: Evaluation of an evidence-based, nurse-driven checklist to prevent hospital-acquired catheter-associated urinary tract infections in intensive care units. J Nurs Care Qual, 2011;26(2):101-109